Ignite Creation Date:
2024-05-06 @ 11:14 AM
Last Modification Date:
2024-10-26 @ 12:42 PM
Study NCT ID:
NCT03462212
Status:
RECRUITING
Last Update Posted:
2021-08-27
First Post:
2018-02-14
Brief Title:
Carboplatin-Paclitaxel-Bevacizumab vs Carbo-Pacli-Beva-Rucaparib vs Carbo-Pacli-Ruca Selected According to HRD Status in Patients With Advanced Ovarian Primary Peritoneal and Fallopian Tube Cancer Preceded by a Phase I Dose Escalation Study on Ruca-Beva Combination
Sponsor:
Fondazione Policlinico Universitario Agostino Gemelli IRCCS
Organization:
Fondazione Policlinico Universitario Agostino Gemelli IRCCS
Key Dates - Follows AllAPIJSON File Order
Start Date:
2021-03-17
Start Date Type:
ACTUAL
Primary Completion Date:
2025-03-01
Primary Completion Date Type:
ESTIMATED
Completion Date:
2025-03-01
Completion Date Type:
ESTIMATED
First Submit Date:
2018-02-14
First Submit QC Date:
March 9 2018
Study First Post Date:
2018-03-12
Study First Post Date Type:
ACTUAL
Results First Submit Date:
None
Results First Submit QC Date:
None
Results First Post Date:
None
Results First Post Date Type:
None
Results First Post QC Date:
None
Results First Post QC Date Type:
None
Disp First Submit Date:
None
Disp First Submit QC Date:
None
Disp First Post Date:
None
Disp First Post Date Type:
None
Last Update Submit Date:
2021-08-24
Last Update Post Date:
2021-08-27
Last Update Post Date Type:
ACTUAL